Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,915
Closed -$46.7K 3771
2026
Q1
$46.7K Sell
30,915
-1,268
-4% -$2.42K ﹤0.01% 3485
2025
Q4
$69.2K Buy
32,183
+19,349
+151% +$66.1K ﹤0.01% 3398
2025
Q3
$61.9K Buy
12,834
+2,309
+22% +$12.6K ﹤0.01% 3410
2025
Q2
$58.4K Buy
10,525
+9,894
+1,568% +$78.3K ﹤0.01% 3391
2025
Q1
$7.74K Buy
+631
New +$9.63K ﹤0.01% 3506
2021
Q4
Sell
-43
Closed -$3K 4310
2021
Q3
$3K Buy
43
+4
+10% +$423 ﹤0.01% 4349
2021
Q2
$7K Buy
39
+3
+8% +$525 ﹤0.01% 4485
2021
Q1
$7K Sell
36
-32
-47% -$6.46K ﹤0.01% 4454
2020
Q4
$14K Buy
68
+34
+100% +$6.31K ﹤0.01% 4276
2020
Q3
$7K Buy
+34
New +$8.19K ﹤0.01% 4219

Other funds holding GOCO

Deutsche Bank's GOCO Position: Q2 2026 in Review

Deutsche Bank sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 30,915 shares — an estimated $46.7K sold.

Deutsche Bank first reported a position in GOCO in Q3 2020 and held it in 10 quarters. The position peaked at $69.2K in Q4 2025. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Deutsche Bank reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Deutsche Bank sold 30,915 GoHealth shares in Q2 2026, an estimated $46.7K.
  • Deutsche Bank first reported a position in GoHealth in Q3 2020 and held it in 10 quarters.
  • Deutsche Bank's GoHealth position peaked at $69.2K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.